nalidixic acid has been researched along with Bacteremia in 15 studies
Bacteremia: The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This paper reports the first case of Haemophilus quentini bacteremia with reduced susceptibility to levofloxacin and resistance to nalidixic acid identified by 16S rRNA sequencing." | 3.73 | Reduced levofloxacin susceptibility and tetracycline resistance in a clinical isolate of Haemophilus quentini identified by 16S rRNA sequencing. ( Ho, PL; Lau, SK; Mak, GC; Tse, CW; Wong, SS, 2005) |
| "The pefloxacin disk assay was approved and implemented by EUCAST (in 2014) and CLSI (in 2015)." | 1.42 | Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica. ( Åhman, J; Kahlmeter, G; Matuschek, E; Petersen, A; Sjölund-Karlsson, M; Skov, R; Stegger, M; Torpdahl, M, 2015) |
| "The empiric treatment of acute pyelonephritis (APN) with third generation cephalosporins (3GC) or fluoroquinolones (FQ) has been challenged by Escherichia coli resistance reported by community surveillance networks." | 1.40 | Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors. ( Caron, F; Choplin-Renard, J; Etienne, M; Pestel-Caron, M; Van Elslande, H, 2014) |
| "Typhoid fever is a food- and water-borne disease, caused by Salmonella enterica serovar Typhi, responsible for high rates of morbidity and mortality in developing countries." | 1.37 | [Antibiotic susceptibility of Salmonella enterica serovar Typhi isolated from blood cultures at the Ain M'lila hospital (Algeria), between 2005 and 2008]. ( Boudersa, F; Bouzenoune, F; Kellab Debbih, K; Kouhil, S; Nezzar, N, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Etienne, M | 1 |
| Van Elslande, H | 1 |
| Choplin-Renard, J | 1 |
| Pestel-Caron, M | 1 |
| Caron, F | 1 |
| Skov, R | 1 |
| Matuschek, E | 1 |
| Sjölund-Karlsson, M | 1 |
| Åhman, J | 1 |
| Petersen, A | 1 |
| Stegger, M | 1 |
| Torpdahl, M | 1 |
| Kahlmeter, G | 1 |
| Gaborieau, V | 1 |
| Weill, FX | 1 |
| Marchou, B | 1 |
| Bouzenoune, F | 1 |
| Kellab Debbih, K | 1 |
| Boudersa, F | 1 |
| Kouhil, S | 1 |
| Nezzar, N | 1 |
| Crump, JA | 1 |
| Medalla, FM | 1 |
| Joyce, KW | 1 |
| Krueger, AL | 1 |
| Hoekstra, RM | 1 |
| Whichard, JM | 1 |
| Barzilay, EJ | 1 |
| Lo, NW | 1 |
| Chu, MT | 1 |
| Ling, JM | 1 |
| MCCABE, WR | 1 |
| BUCHBINDER, M | 1 |
| KUNIN, SS | 1 |
| SALEH, J | 1 |
| Slinger, R | 1 |
| Desjardins, M | 1 |
| McCarthy, AE | 1 |
| Ramotar, K | 1 |
| Jessamine, P | 1 |
| Guibord, C | 1 |
| Toye, B | 1 |
| Mak, GC | 1 |
| Ho, PL | 1 |
| Tse, CW | 1 |
| Lau, SK | 1 |
| Wong, SS | 1 |
| Cattoir, V | 1 |
| Lesprit, P | 1 |
| Lascols, C | 1 |
| Denamur, E | 1 |
| Legrand, P | 1 |
| Soussy, CJ | 1 |
| Cambau, E | 1 |
| Dimitrov, T | 1 |
| Udo, EE | 1 |
| Albaksami, O | 1 |
| Kilani, AA | 1 |
| Shehab, EMR | 1 |
| Kulwichit, W | 1 |
| Chatsuwan, T | 1 |
| Unhasuta, C | 1 |
| Pulsrikarn, C | 1 |
| Bangtrakulnonth, A | 1 |
| Chongthaleong, A | 1 |
| González-López, JJ | 1 |
| Larrosa, N | 1 |
| Planes, AM | 1 |
| Bartolomé-Comas, RM | 1 |
| Gómez, JL | 1 |
| Alos, JI | 1 |
| Amor, E | 1 |
| Cogollos, R | 1 |
| Pérez, A | 1 |
| Mascellino, MT | 1 |
| Farinelli, S | 1 |
| Iegri, F | 1 |
| Iona, E | 1 |
15 other studies available for nalidixic acid and Bacteremia
| Article | Year |
|---|---|
Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
Topics: Acute Disease; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Catchment Area, Heal | 2014 |
Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica.
Topics: Anti-Bacterial Agents; Bacteremia; Base Sequence; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; | 2015 |
[A case of Salmonella enterica serovar typhi with decreased susceptibility to ciprofloxacin].
Topics: Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; | 2010 |
[Antibiotic susceptibility of Salmonella enterica serovar Typhi isolated from blood cultures at the Ain M'lila hospital (Algeria), between 2005 and 2008].
Topics: Algeria; Ampicillin; Anti-Bacterial Agents; Bacteremia; Catchment Area, Health; Chloramphenicol; Dev | 2011 |
Antimicrobial resistance among invasive nontyphoidal Salmonella enterica isolates in the United States: National Antimicrobial Resistance Monitoring System, 1996 to 2007.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacteremia; Ceftriaxo | 2011 |
Increasing quinolone resistance and multidrug resistant isolates among Salmonella enterica in Hong Kong.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Child; Child, Prescho | 2012 |
BACTERIURIA AND BACTEREMIA WITH GENITOURINARY SURGERY: MODIFICATION BY ANTIMICROBIAL PROPHYLAXIS.
Topics: Anti-Infective Agents; Bacteremia; Bacteriuria; Drug Therapy; Nalidixic Acid; Naphthyridines; Postop | 1963 |
Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
Topics: Anti-Infective Agents; Bacteremia; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Micr | 2004 |
Reduced levofloxacin susceptibility and tetracycline resistance in a clinical isolate of Haemophilus quentini identified by 16S rRNA sequencing.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; DNA, Bacterial; Drug Resistance, Mul | 2005 |
In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; DNA Topoisomerases; Drug Resistance; Escherichia coli; Esch | 2006 |
Ciprofloxacin treatment failure in a case of typhoid fever caused by Salmonella enterica serotype Paratyphi A with reduced susceptibility to ciprofloxacin.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacteria | 2007 |
Drug-resistant nontyphoidal Salmonella bacteremia, Thailand.
Topics: Anti-Infective Agents; Bacteremia; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Humans; M | 2007 |
[About a patient with nalidixic-acid-resistant Salmonella enterica serotype typhi infection. Therapeutic management].
Topics: Adolescent; Bacteremia; Bacterial Proteins; Campylobacter Infections; Campylobacter jejuni; DNA Gyra | 2007 |
[Bacteremia caused by Campylobacter jejuni resistant to nalidixic acid and fluoroquinolones].
Topics: Adult; Bacteremia; Campylobacter Infections; Campylobacter jejuni; Cephalothin; Diarrhea; Drug Resis | 1993 |
The influence of the SOS response on the activity of 4-quinolones and zidovudine against some strains of Enterobacteria.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Anti-Infective Agents; Bacteremia; Ciproflox | 1998 |